News Alert Archives | Page 2 of 27

June 20, 2025

Published by Med Search on June 20, 2025

Categories

Medscape

EMA Recommends Rezdiffra for MASH Liver Fibrosis EMA Recommends Rezdiffra for MASH Liver Fibrosis

The European Medicines Agency (EMA) has recommended conditional marketing authorization for Rezdiffra (resmetirom) for adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate-to-advanced liver fibrosis. MASH […]

June 20, 2025

Published by Med Search on June 20, 2025

Categories

Medscape

FDA Approves Dupilumab for Bullous Pemphigoid FDA Approves Dupilumab for Bullous Pemphigoid

Dupilumab has been approved by the FDA for the treatment bullous pemphigoid in adults, the manufacturer Regeneron announced. Dupilumab (Dupixent), a human monoclonal antibody that inhibits […]

June 20, 2025

Published by Med Search on June 20, 2025

Categories

Medscape

Europe Recommends Stem Cell Therapy for Blood Cancers Europe Recommends Stem Cell Therapy for Blood Cancers

At its June 2025 meeting, the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) gave a recommendation for conditional marketing authorization in […]

June 20, 2025

Published by Med Search on June 20, 2025

Categories

Medscape

HIV Prevention Vaginal Ring Recommended for 16-Year-Olds HIV Prevention Vaginal Ring Recommended for 16-Year-Olds

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended an extension of indication for dapivirine vaginal ring 25 mg to […]

June 20, 2025

Published by Med Search on June 20, 2025

Categories

Medscape

Exceptional Use Recommendation for Nuclear Emergency Drug Exceptional Use Recommendation for Nuclear Emergency Drug

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended an exceptional circumstances marketing authorization for Imreplys. The drug — active […]

June 19, 2025

Published by Med Search on June 19, 2025

Categories

Medscape

NICE Rejects Alzheimer’s Drugs Over Limited Benefit for Cost NICE Rejects Alzheimer’s Drugs Over Limited Benefit for Cost

Two new drugs to treat Alzheimer’s disease have been rejected for NHS use in England and Wales because they are too expensive to justify their “relatively […]

June 16, 2025

Published by Med Search on June 16, 2025

Categories

Medscape

DMD Gene Therapy Elevidys Halted After Second Patient Death DMD Gene Therapy Elevidys Halted After Second Patient Death

Sarepta Therapeutics has temporarily suspended use of the gene therapy Elevidys in non-ambulatory patients with Duchenne muscular dystrophy (DMD) after a second patient taking the drug […]

June 13, 2025

Published by Med Search on June 13, 2025

Categories

Medscape

Perioperative Pembro Approved to Up Chance of HNSCC Cure Perioperative Pembro Approved to Up Chance of HNSCC Cure

The FDA has approved a before and after surgery regimen for pembrolizumab to improve outcomes in resectable locally-advanced head and neck squamous cell carcinoma (HNSCC). Specifically, […]

June 13, 2025

Published by Med Search on June 13, 2025

Categories

Medscape

FDA Bucks Advisors to Approve Mitomycin for NMIBC FDA Bucks Advisors to Approve Mitomycin for NMIBC

The FDA has approved mitomycin intravesical solution (Zusduri, UroGen Pharma) for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer. The intravesical mitomycin formulation is meant to be […]